Active Ingredient (In Each Tablet)
Guaifenesin 400 mg
The following Structured Product Label (SPL) was submitted to the FDA by Ulai Health Llc for the product Pharbinex (NDC 73057-379). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 400 mg
Expectorant
These could be sings of a serious illness.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
| adults and children 12 years of age and over | take 1 tablet every 4 hours as needed |
| children 6 to under 12 years of age | take ½ tablet every 4 hours as needed |
| children under 6 years of age | ask a doctor |
store at 200- 250C (680-770F)
magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, silicon dioxide, stearic acid
(866) 562-2756 (Mon-Fri 8 AM to 4 PM EST)
TAMPER EVIDENT: DO NOT USE IF SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
*This product is not manufactured or distributed by Reckitt Benckiser LLC, owner of registered trademark Mucinex®
Distributed by:
ULAI HEALTH LLC.
Alexandria, VA 22312
PHARBEST
NDC 73057-379-04
Manufactured in the USA
Immediate Release
PHARBINEX
*Compare to the active ingredient in Mucinex® Tablets
Guaifenesin 400mg
Expectorant
30 TABLETS
* Please review the disclaimer below.